Cargando…

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy

INTRODUCTION: Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease and is influenced by sex hormones. Our aim was to investigate changes in visceral fat and the ratio of visceral fat to total body fat (VAT/TBF) and their associations with changes in lipids and insulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klaver, Maartje, van Velzen, Daan, de Blok, Christel, Nota, Nienke, Wiepjes, Chantal, Defreyne, Justine, Schreiner, Thomas, Fisher, Alessandra, Twisk, Jos, Seidell, Jaap, T’Sjoen, Guy, den Heijer, Martin, de Mutsert, Renée
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684493/ https://www.ncbi.nlm.nih.gov/pubmed/34415999 http://dx.doi.org/10.1210/clinem/dgab616

Ejemplares similares

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021)

SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Defreyne, Justine, et al.
Publicado: (2020)

Change in grip strength in trans people and its association with lean body mass and bone density
por: Scharff, Miranda, et al.
Publicado: (2019)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Is Type 1 Diabetes Mellitus More Prevalent Than Expected in Transgender Persons? A Local Observation
por: Defreyne, Justine, et al.
Publicado: (2017)

SAT-014 No Correlation between Serum Testosterone Levels and Aggression or Anger Intensity in Transgender People: Results from Five European Centres
por: Defreyne, Justine, et al.
Publicado: (2019)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy
por: Collet, Sarah, et al.
Publicado: (2022)

OR27-05 Sexual Desire Changes in Transgender Individuals upon Initiation of Hormone Treatment; Results from the Longitudinal ENIGI Study
por: Defreyne, Justine, et al.
Publicado: (2020)

The Role of Estrone in Feminizing Hormone Treatment
por: Tebbens, Marieke, et al.
Publicado: (2021)

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
por: de Blok, Christel J M, et al.
Publicado: (2019)

Transgender Girls Grow Tall: Adult Height Is Unaffected by GnRH Analogue and Estradiol Treatment
por: Boogers, Lidewij Sophia, et al.
Publicado: (2022)

Health considerations for transgender women and remaining unknowns: a narrative review
por: Iwamoto, Sean J., et al.
Publicado: (2019)

Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth
por: Nokoff, Natalie J, et al.
Publicado: (2019)

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
por: de Nie, Iris, et al.
Publicado: (2020)

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study
por: Wiepjes, Chantal M, et al.
Publicado: (2019)

The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives
por: Cocchetti, Carlotta, et al.
Publicado: (2022)

Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
por: Wiepjes, C. M., et al.
Publicado: (2020)

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI)
por: Cocchetti, C., et al.
Publicado: (2022)

Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Matthys, Imke, et al.
Publicado: (2021)

Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women
por: Elffers, Theodora W., et al.
Publicado: (2017)

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Characterization of the (1)H-MRS Metabolite Spectra in Transgender Men with Gender Dysphoria and Cisgender People
por: Collet, Sarah, et al.
Publicado: (2021)

Metabolomics: a search for biomarkers of visceral fat and liver fat content
por: Boone, Sebastiaan, et al.
Publicado: (2019)

Experiences of Transgender Women with Speech Feminization Training: A Qualitative Study
por: Leyns, Clara, et al.
Publicado: (2022)

Gender affirming hormonal treatment in Danish transgender persons: A nationwide register‐based study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Socioeconomic status in Danish transgender persons: a nationwide register-based cohort study
por: Glintborg, Dorte, et al.
Publicado: (2021)

Milk fat biomarkers and cardiometabolic disease
por: Risérus, Ulf, et al.
Publicado: (2017)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Minority Stress and the Effects on Emotion Processing in Transgender Men and Cisgender People: A Study Combining fMRI and (1)H-MRS
por: Kiyar, Meltem, et al.
Publicado: (2021)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study
por: Goldberg, Ronald B, et al.
Publicado: (2021)

Insulin resistance in transgender individuals correlates with android fat mass
por: Bretherton, Ingrid, et al.
Publicado: (2021)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
por: de Blok, Christel JM., et al.
Publicado: (2021)

Corrigendum to: “Hepatic Fat in Participants With and Without Incident Diabetes in the Diabetes Prevention Program Outcome Study”
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h54sa5s5dlv58jjoohuetp0j9n